Apart from few studies evaluating the impact of preoperative CA125 serum levels on outcome [14,15], studies investigating the role of MUC16 expression in tumor tissue from CCA patients remain scarce so far. This evidence concerns the gene MUC16 and cholangiocarcinoma.